Treatment of systemic fungal infections with liposomal amphotericin B.
about
Lipid-based amphotericin B for the treatment of fungal infections.Antifungal pharmacodynamics: review of the literature and clinical applications.Coccidioidomycosis in solid organ transplantation.Antifungal agents: chemotherapeutic targets and immunologic strategies.Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasisPharmacokinetics of liposomal amphotericin B (Ambisome) in critically ill patientsComparison of nephrotoxicities of different polyoxyethyleneglycol formulations of amphotericin B in rats.Efficacy of intravenous itraconazole against experimental pulmonary aspergillosis.From synthesis to function via iterative assembly of N-methyliminodiacetic acid boronate building blocks.Amphotericin B lipid complex therapy of experimental fungal infections in miceComparative efficacy of amphotericin B colloidal dispersion and amphotericin B deoxycholate suspension in treatment of murine coccidioidomycosis.Efficacy and safety of amphotericin B colloidal dispersion compared with those of amphotericin B deoxycholate suspension for treatment of disseminated murine cryptococcosis.Lipid-associated methylpheophorbide-a (hexyl-ether) as a photodynamic agent in tumor-bearing mice.Systemic Candida infections.Fungal infection in a dissecting aneurysm of the thoracic aorta.Efficacy of liposomal amphotericin B in treatment of systemic murine fusariosis.Antifungal agents in neonatal systemic candidiasisEvaluation of renal toxicity and antifungal activity of free and liposomal amphotericin B following a single intravenous dose to diabetic rats with systemic candidiasis.Efficacy of prophylactic aerosol amphotericin B lipid complex in a rat model of pulmonary aspergillosis.Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studiesHeat-induced superaggregation of amphotericin B reduces its in vitro toxicity: a new way to improve its therapeutic index.Comparative efficacies of amphotericin B lipid complex and amphotericin B deoxycholate suspension against murine blastomycosis.Concentrations in serum and distribution in tissue of free and liposomal amphotericin B in rats during continuous intralipid infusion.Use of nebulised liposomal amphotericin B in the treatment of Aspergillus fumigatus empyema.Systemic antifungal drugs: Are we making any progress?Comparative pharmacokinetics of enrofloxacin and tissue concentrations of parent drug and ciprofloxacin after intramuscular administrations of free and liposome-encapsulated enrofloxacin in rabbits.Tissue distribution of amphotericin B lipid complex in laboratory animals.
P2860
Q33604227-6CE9D5EE-FBFE-43CC-9162-63E70D210839Q34083129-3B367099-AE6B-4C01-BF8A-C2F6803EE3F8Q34392977-106870A6-768F-4835-9EBA-4A4D77A3F9ADQ34400044-5B733A47-79C9-4D3D-B9F3-8302FFA77D41Q34529190-A25C95A1-1963-49E3-99F0-46DFABF7C194Q35136556-75DB99E9-8A0D-4DA2-B853-FD13D0D4C804Q35885347-A3F65925-B67A-4D44-BEF8-28E5C157A2F8Q35904922-9EB5CF1F-4EEE-4CE6-8454-F849BBBC868FQ36396226-3DAE06CF-8AD0-4A93-8B98-0A8DA668D2B7Q36753279-F56F2637-9B52-437A-8C6D-70725372B2EDQ36754865-D780A42F-8BE9-4613-8182-F176282FAFB3Q36758184-9675180C-7C95-42F5-9DC0-B6E3727479ACQ36762855-155C9080-66D6-403B-A8DB-1D22D3701E68Q36987671-C5D4B9EC-2352-4709-99DC-97A1A51C565FQ38704726-43D67175-34BD-4B7A-A284-B6A928AAB927Q39652173-A02E8717-1503-495B-86C4-D0B550C06D56Q39779942-13CB7E4B-BF60-4BC2-8AD6-079DAB84F966Q39782548-4DB1631C-084D-4CAA-ADC4-728F5D698701Q39783583-A3B7DD4D-A14C-4373-9AFA-793AF34F1A2DQ39785066-05B90046-570F-4231-9BA6-F4B323BB4AA4Q39785217-55074141-856B-4865-8D23-363C563196C9Q40087802-49E499DC-E514-4CE1-9421-5946CB4BC30EQ40286515-EE606853-0B3C-4B87-B837-198F85936C02Q42573016-95A87930-1B26-449D-B089-ECD74181BEB2Q42576812-5EBBFFAA-883A-428D-80FC-E64A9C74B64FQ44251232-F5AEFFC7-6BA0-45B6-9838-7B4F5F17ECA7Q50799275-24EB98B7-640F-44C0-8E7D-D5E7B33C126F
P2860
Treatment of systemic fungal infections with liposomal amphotericin B.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Treatment of systemic fungal infections with liposomal amphotericin B.
@en
type
label
Treatment of systemic fungal infections with liposomal amphotericin B.
@en
prefLabel
Treatment of systemic fungal infections with liposomal amphotericin B.
@en
P2093
P1476
Treatment of systemic fungal infections with liposomal amphotericin B.
@en
P2093
Fainstein V
Frankel LS
Lopez-Berestein G
P304
P356
10.1001/ARCHINTE.149.11.2533
P407
P577
1989-11-01T00:00:00Z